Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment.
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2012
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Novartis
- 18 Apr 2012 Actual patient number is 13 according to ClinicalTrials.gov.
- 18 Apr 2012 Actual end date (Mar 2005) added as reported by ClinicalTrials.gov.
- 02 Oct 2009 New trial record